Verition Fund Management’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
SCM
S
Verition Fund Management's NVAX Position: Q3 2025 in Review
Verition Fund Management sold out of Novavax (NVAX) in Q3 2025, closing a stake of 146,647 shares — an estimated $924K sold.
Verition Fund Management first reported a position in NVAX in Q4 2013 and held it in 13 quarters. The position peaked at $2.27M in Q4 2024. 249 funds tracked by Wall St. Rank hold NVAX as of Q3 2025.
- Verition Fund Management reported no remaining Novavax position as of Q3 2025 after selling out during the quarter.
- Verition Fund Management sold 146,647 Novavax shares in Q3 2025, an estimated $924K.
- Verition Fund Management first reported a position in Novavax in Q4 2013 and held it in 13 quarters.
- Verition Fund Management's Novavax position peaked at $2.27M in Q4 2024.
- 249 funds tracked by Wall St. Rank held Novavax as of Q3 2025.
Based on Verition Fund Management's 13F filing for Q3 2025, filed 14 Nov 2025.